Kurser indlæses...
Prognose
Vi har ingen analytikerdata for denne virksomhed.
Nyheder Til nyhedsfeedet
Animalcare Group delisted from AIM after takeover by Charterhouse subsidiary
The shares of Animalcare Group were removed from trading on the AIM of the London Stock Exchange on Wednesday morning after CCP PAW 2 Limited — a 100% subsidiary of funds managed/advised by Charterhouse Capital Partners — acquired the company via a scheme of arrangement under Part 26 of the Companies Act 2006. The scheme took effect on Wednesday; Animalcare plans to convert into a private limited company. Financial and legal advisers on the transaction included Rothschild & Co, Stifel Nicolaus Europe, Panmure Liberum, Allen & Overy and Squire Patton Boggs. » Mere på de.investing.com
Animalcare Group issues 967,954 new shares after option exercise
Following court approval of the takeover scheme and the exercise of outstanding options, Animalcare Group has issued 967,954 new ordinary shares. The exercise followed the takeover announcement by CCP PAW 2 Limited (Charterhouse) and rendered the options vested and exercisable under Rule 15 of the Takeover Code. The new shares are expected to be admitted to trading on AIM on Tuesday at around 08:00; issued share capital rises to 70,013,899 shares of 20 pence each. CEO Jennifer Winter received 468,797 shares (total 569,447; 0.81%) and CFO Christopher Brewster 188,384 shares (total 473,897; 0.68%). » Mere på de.investing.com
JPMorgan increases stake in Animalcare Group to 6.356%
JPMorgan Chase & Co. has increased its voting stake in the Animalcare Group to 6.356% and now holds 4,388,686 voting rights. The position comprises 6.351% direct share voting rights via J.P. Morgan Securities PLC and 0.005% through cash-settled equity swaps with maturities to November 2026 and July 2027. The notification was made in accordance with UK disclosure requirements. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | december 2025 | YoY |
|---|---|---|
| Omsætning | 51,98 mio. | - |
| Bruttofortjeneste | 25,51 mio. | - |
| Nettoresultat | 2,08 mio. | - |
| EBITDA | 9,3 mio. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 277,23 mio. € |
Antal aktier | 69,05 mio. |
Højeste/laveste i 52 uger | 4,08 € - 2,59 € |
Udbytteafkast | 0,64 % |
Udbytte TTM | 0,0249 € |
Beta | 0,67 |
P/E (PE Ratio) | 45,39 |
PEG (PEG Ratio) | -0,53 |
K/I (PB Ratio) | 2,02 |
P/S (PS Ratio) | 2,60 |
Virksomhedsprofil
Animalcare Group plc udvikler, sælger og distribuerer licenserede veterinærlægemidler og identifikationsprodukter samt tjenester til selskabsdyr, produktionsdyr og heste på det veterinære marked. Selskabet er også involveret i engros- og markedsføring af veterinærlægemidler. Selskabet betjener kunder i Belgien, Holland, Storbritannien, Tyskland, Spanien, Italien, Portugal, andre europæiske lande, Asien, Mellemøsten, Afrika og internationalt. Animalcare Group plc blev stiftet i 1972 og har hjemsted i York, Storbritannien.
| Navn | ANIMALCARE GROUP |
| CEO | Jennifer Ann Julia Winter |
| Hjemsted | York,
ny Storbritannien |
| Websted | |
| Børsnotering | 15.01.2008 |
| Medarbejdere | 220 |
Deep Dive
Tickersymboler
| Børs | Symbol |
|---|---|
London Stock Exchange | ANCR.L |
London | ANCR.L |